ClinicalTrials.Veeva

Menu
C

CITrials | Bellflower, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KarXT
MK-8189
Ralmitaront
RO6889450
Brexpiprazole
Troriluzole
SEP-363856
BPN14770
MK-8189-008
TRx0237

Parent organization

This site is a part of CITrials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 23 total trials

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compul...

Enrolling
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

A Randomized, Double-blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients with Early Alzheimer's Di...

Active, not recruiting
Alzheimer's Disease
Drug: BPN14770
Drug: Placebo

Trial sponsors

Otsuka logo
Karuna Therapeutics logo
Roche logo
Biohaven logo
Merck Sharp & Dohme (MSD) logo
Allergan logo
A
B
C
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems